InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: robi-1-kenobi post# 76208

Tuesday, 11/05/2013 9:39:27 PM

Tuesday, November 05, 2013 9:39:27 PM

Post# of 146240

No Tox effects: ~75-99% odds

I think there are very good odds of perfectly clean MFD (max feasible dose) Tox results - IMHO odds of maybe 75-99% (I would make a more precise prediction if I knew the MFD used in g/kg). Stock should go up hugely, but many investors may not bid it up due to waiting on GLP Tox start and results.

But my DD findings are that GLP testing will not exceed the MFD used in this non-GLP study and more animals and different species are not likely to be affected differently as the mechanism of action for FluCide is extracellular and elimination is principally glomerular filtration by kidneys - and both will be similar across species. If the stock price gains are muted, this might be a good opportunity to buy.
~ Robi-1-kenobi



The Company expects to receive a complete report of all laboratory and clinical data including blood chemistry and histopathology analysis soon. http://www.barchart.com/headlines/story/403489/nanoviricides-says-early-results-indicate-that-flucide-r-was-extremely-safe-in-a-non-glp-small-animal-tox-study

The market size for anti-influenza drugs is currently estimated to be in several billions of dollars worldwide. The Company believes that if its FluCide(R) drug becomes available, the influenza drug market size could become substantially larger. It is well known that when an effective treatment for a disease becomes available, the market size explodes and the novel effective treatment captures a substantial portion of the market.

Thank you Robi-1-kenobi

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News